|
시장보고서
상품코드
2052144
일차 간세포 시장 : 시장 인사이트, 경쟁 구도 및 시장 예측(2033년)Primary Hepatocytes Market Insights, Competitive Landscape, and Market Forecast - 2033 |
||||||
신약 개발, 독성 테스트 및 간 질환 연구에서 첨단 세포 기반 연구 모델에 대한 수요가 증가함에 따라 일차 간세포 시장은 크게 성장하고 있습니다. 일차 간세포는 약물 대사, 간독성 및 간 기능 연구에 널리 이용되고 있으며, 제약 및 생명공학 연구에 필수적인 도구로 활용되고 있습니다. 신약개발의 실패를 줄이고 예측 정확도가 높은 전임상 모델 개선에 대한 관심이 높아지면서 시장 확대에 더욱 박차를 가하고 있습니다. 일차 간세포 시장 규모는 2026년 2,746억 달러, 2033년까지 4,295억 달러에 달할 것으로 예상되며, 예측 기간 동안 CAGR 6.60%로 성장할 것으로 예상됩니다.
시장 인사이트:
3D 간세포 배양 시스템, 냉동 보존 간세포 및 고급 체외 간 모델의 채택이 진행됨에 따라 이 산업은 빠른 속도로 발전하고 있습니다. 제약 및 생명공학 기업들은 정확한 약물 대사 및 독성 평가를 위해 1차 간세포에 대한 의존도를 높이고 있습니다. 세포의 분리, 보존, 배양 기술의 혁신으로 세포의 생존율과 기능이 향상되어 보다 신뢰할 수 있는 연구 결과를 얻을 수 있게 되었습니다. 또한, 맞춤형 의료 및 재생의료 연구에서의 간세포 기반 분석법 활용이 확대되면서 시장 성장에 기여하고 있습니다.
촉진요인:
간세포 치료제 시장의 주요 촉진요인으로는 신약 개발 및 개발에 대한 투자 증가, 간질환 유병률 증가, 예측 독성 연구에 대한 관심 증가 등이 있습니다. 제약 및 바이오 제약 산업은 지속적으로 확대되고 있으며, 전임상시험의 효율성을 높이기 위해 신뢰할 수 있는 간세포 모델에 대한 수요를 주도하고 있습니다. 규제 당국도 동물 실험을 줄이기 위해 첨단 체외 모델 사용을 권장하고 있으며, 이는 일차 간세포의 채택을 더욱 촉진하고 있습니다. 또한, 줄기세포 생물학 및 재생의료 분야의 연구 활동이 활발해지면서 시장에 더 많은 성장 기회를 창출하고 있습니다.
비즈니스 기회:
이 시장은 고품질 동결보존 간세포, 3D 구형 모델 및 특수 분석 플랫폼을 개발하는 기업에게 큰 비즈니스 기회를 제공하고 있습니다. 신흥국에서는 연구 인프라가 잘 갖추어져 있고, 생명공학 분야에 대한 투자가 증가하고 있어 매력적인 확장 가능성이 기대되고 있습니다. 학술기관, 위탁연구기관, 생명공학 기업 간의 협력을 통해 간세포 기반 응용 분야의 혁신이 가속화될 것으로 예상됩니다. 또한, 바이오엔지니어링과 장기칩 기술의 발전은 향후 몇 년 동안 시장 진입 기업들에게 새로운 기회를 창출할 수 있습니다.
지역별 분석:
북미는 활발한 제약 연구 활동, 첨단 생명공학 인프라, 신약개발 프로그램에 대한 막대한 투자로 인해 간세포 치료제 시장을 독점하고 있습니다. 주요 시장 기업의 존재와 첨단 세포 배양 기술의 채택 확대는 이 지역의 성장을 더욱 촉진하고 있습니다. 유럽은 연구 자금의 증가와 대체 시험법에 대한 관심의 증가로 인해 큰 시장 점유율을 차지하고 있습니다. 아시아태평양은 생명공학 산업의 확대, 임상 연구 활동의 증가, 중국, 인도, 일본 등의 국가에서 의료 투자 증가에 힘입어 예측 기간 동안 가장 빠른 성장세를 보일 것으로 예상됩니다. 라틴아메리카와 중동 및 아프리카는 연구 역량의 향상과 첨단 세포 기반 분석에 대한 인식이 높아지면서 점차 유망한 시장으로 부상하고 있습니다.
주요 기업:
- Thermo Fisher Scientific Inc.
- Corning Inc.
- Lonza
- Takara Bio Inc.
- Cell Biologics, Inc.
- Merck KGaA
- American Type Culture Collection(ATCC)
- Creative Bioarray
- Axol Bioscience Ltd.
- HiMedia Laboratories
세분화:
제품별
- 동결보존 현탁 간세포
- 생 현탁액 간세포
- 3D(구형) 간세포
- 증식된 간세포(플레이트 배양 가능)
- 특성 분석되지 않은 간세포
종류
- 인간
- 쥐
- 마우스
- 개
- 원숭이
- 말
- 기타
용도 및 분석별
- 세포 생존율 분석
- 시토크롬 효소 활성
- 고처리량 세포 독성 분석법
- 트랜스포터 억제 분석
- in vitro 내인성 클리어런스
- 인지질 분석
- 기타
최종사용자별
- 바이오제약 기업
- 학술·연구기관
- 위탁연구기관
지역별
- 북미
- 북미
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
목차
제1장 주요 요약
제2장 시장 개요
제3장 세계의 일차 간세포 시장 전망, 2020-2033년
제4장 북미의 일차 간세포 시장 전망, 2020-2033년
제5장 유럽의 일차 간세포 시장 전망, 2020-2033년
제6장 아시아태평양의 일차 간세포 시장 전망, 2020-2033년
제7장 라틴아메리카의 일차 간세포 시장 전망, 2020-2033년
제8장 중동 및 아프리카의 일차 간세포 시장 전망, 2020-2033년
제9장 경쟁 구도
제10장 부록
KSM 26.06.11The primary hepatocytes market is witnessing significant growth due to increasing demand for advanced cell-based research models in drug discovery, toxicology testing, and liver disease research. Primary hepatocytes are widely utilized for studying drug metabolism, hepatotoxicity, and liver function, making them essential tools in pharmaceutical and biotechnology research. Growing emphasis on reducing drug development failures and improving predictive preclinical testing models is further supporting market expansion. The Primary Hepatocytes Market is expected to reach US$ 274.6 Bn in 2026 and US$ 429.5 Bn by 2033, growing at a CAGR of 6.60% during the forecast period.
Market Insights:
The industry is experiencing rapid advancement with the increasing adoption of 3D hepatocyte culture systems, cryopreserved hepatocytes, and advanced in vitro liver models. Pharmaceutical and biotechnology companies are increasingly relying on primary hepatocytes for accurate drug metabolism and toxicity assessments. Technological innovations in cell isolation, preservation, and culture techniques are enhancing cell viability and functionality, enabling more reliable research outcomes. Additionally, the growing use of hepatocyte-based assays in personalized medicine and regenerative medicine research is contributing to market growth.
Drivers:
Key drivers of the primary hepatocytes market include rising investment in drug discovery and development, increasing prevalence of liver diseases, and growing focus on predictive toxicology studies. The expanding pharmaceutical and biopharmaceutical industries are driving demand for reliable liver cell models to improve the efficiency of preclinical testing. Regulatory agencies are also encouraging the use of advanced in vitro models to reduce animal testing, further boosting adoption of primary hepatocytes. Moreover, increasing research activities in stem cell biology and regenerative medicine are creating additional growth opportunities for the market.
Business Opportunity:
The market presents substantial business opportunities for companies developing high-quality cryopreserved hepatocytes, 3D spheroid models, and specialized assay platforms. Emerging economies are offering attractive expansion potential due to increasing research infrastructure development and growing investment in biotechnology sectors. Collaborations between academic institutions, contract research organizations, and biotechnology firms are expected to accelerate innovation in hepatocyte-based applications. Furthermore, advancements in bioengineering and organ-on-chip technologies are likely to create new opportunities for market participants in the coming years.
Region Analysis:
North America dominates the primary hepatocytes market owing to strong pharmaceutical research activities, advanced biotechnology infrastructure, and significant investment in drug discovery programs. The presence of major market players and increasing adoption of advanced cell culture technologies further support regional growth. Europe holds a substantial market share due to rising research funding and increasing focus on alternative testing methods. Asia Pacific is anticipated to witness the fastest growth during the forecast period driven by expanding biotechnology industries, increasing clinical research activities, and rising healthcare investments in countries such as China, India, and Japan. Latin America and the Middle East & Africa are gradually emerging as promising markets due to improving research capabilities and growing awareness regarding advanced cell-based assays.
Key Players:
- Thermo Fisher Scientific Inc.
- Corning Inc.
- Lonza
- Takara Bio Inc.
- Cell Biologics, Inc.
- Merck KGaA
- American Type Culture Collection (ATCC)
- Creative Bioarray
- Axol Bioscience Ltd.
- HiMedia Laboratories
Segmentation:
By Product
- Cryopreserved Suspension Hepatocytes
- Fresh Suspension Hepatocytes
- 3D (Spheroid) Hepatocytes
- Expanded Hepatocytes (Plateable)
- Non-characterized Hepatocytes
By Species
- Human
- Rat
- Mouse
- Dog
- Monkey
- Horse
- Others
By Application/Assay
- Cell Viability Assay
- Cytochrome Enzyme Activity
- High Content Cytotoxicity
- Transporter Inhibition Assay
- In Vitro Intrinsic Clearance
- Phospholipids Assay
- Others
By End User
- Biopharmaceutical companies
- Academic and Research institutes
- Contract Research Organizations
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- The Middle East & Africa
Table of Contents
1. Executive Summary
- 1.1. Global Primary Hepatocytes Market Snapshot
- 1.2. Future Projections
- 1.3. Key Market Trends
- 1.4. Regional Snapshot, by Value, 2026
- 1.5. Analyst Recommendations
2. Market Overview
- 2.1. Market Definitions and Segmentations
- 2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Market Opportunities
- 2.3. Value Chain Analysis
- 2.4. COVID-19 Impact Analysis
- 2.5. Porter's Five Forces Analysis
- 2.6. Impact of Russia-Ukraine Conflict
- 2.7. PESTLE Analysis
- 2.8. Regulatory Analysis
- 2.9. Price Trend Analysis
- 2.9.1. Current Prices and Future Projections, 2025-2033
- 2.9.2. Price Impact Factors
3. Global Primary Hepatocytes Market Outlook, 2020 - 2033
- 3.1. Global Primary Hepatocytes Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 3.1.1. Cryopreserved Suspension Hepatocytes
- 3.1.2. Fresh Suspension Hepatocytes
- 3.1.3. 3D (Spheroid) Hepatocytes
- 3.1.4. Expanded Hepatocytes (Plateable)
- 3.1.5. Non-characterized Hepatocytes
- 3.2. Global Primary Hepatocytes Market Outlook, by Species, Value (US$ Bn), 2020-2033
- 3.2.1. Human
- 3.2.2. Rat
- 3.2.3. Mouse
- 3.2.4. Dog
- 3.2.5. Monkey
- 3.2.6. Horse
- 3.2.7. Others
- 3.3. Global Primary Hepatocytes Market Outlook, by Application/Assay, Value (US$ Bn), 2020-2033
- 3.3.1. Cell Viability Assay
- 3.3.2. Cytochrome Enzyme Activity
- 3.3.3. High Content Cytotoxicity
- 3.3.4. Transporter Inhibition Assay
- 3.3.5. In Vitro Intrinsic Clearance
- 3.3.6. Phospholipids Assay
- 3.3.7. Others
- 3.4. Global Primary Hepatocytes Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 3.4.1. Biopharmaceutical companies
- 3.4.2. Academic and Research institutes
- 3.4.3. Contract Research Organizations
- 3.5. Global Primary Hepatocytes Market Outlook, by Region, Value (US$ Bn), 2020-2033
- 3.5.1. North America
- 3.5.2. Europe
- 3.5.3. Asia Pacific
- 3.5.4. Latin America
- 3.5.5. Middle East & Africa
4. North America Primary Hepatocytes Market Outlook, 2020 - 2033
- 4.1. North America Primary Hepatocytes Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 4.1.1. Cryopreserved Suspension Hepatocytes
- 4.1.2. Fresh Suspension Hepatocytes
- 4.1.3. 3D (Spheroid) Hepatocytes
- 4.1.4. Expanded Hepatocytes (Plateable)
- 4.1.5. Non-characterized Hepatocytes
- 4.2. North America Primary Hepatocytes Market Outlook, by Species, Value (US$ Bn), 2020-2033
- 4.2.1. Human
- 4.2.2. Rat
- 4.2.3. Mouse
- 4.2.4. Dog
- 4.2.5. Monkey
- 4.2.6. Horse
- 4.2.7. Others
- 4.3. North America Primary Hepatocytes Market Outlook, by Application/Assay, Value (US$ Bn), 2020-2033
- 4.3.1. Cell Viability Assay
- 4.3.2. Cytochrome Enzyme Activity
- 4.3.3. High Content Cytotoxicity
- 4.3.4. Transporter Inhibition Assay
- 4.3.5. In Vitro Intrinsic Clearance
- 4.3.6. Phospholipids Assay
- 4.3.7. Others
- 4.4. North America Primary Hepatocytes Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 4.4.1. Biopharmaceutical companies
- 4.4.2. Academic and Research institutes
- 4.4.3. Contract Research Organizations
- 4.5. North America Primary Hepatocytes Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 4.5.1. U.S. Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 4.5.2. U.S. Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 4.5.3. U.S. Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 4.5.4. U.S. Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 4.5.5. Canada Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 4.5.6. Canada Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 4.5.7. Canada Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 4.5.8. Canada Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 4.6. BPS Analysis/Market Attractiveness Analysis
5. Europe Primary Hepatocytes Market Outlook, 2020 - 2033
- 5.1. Europe Primary Hepatocytes Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 5.1.1. Cryopreserved Suspension Hepatocytes
- 5.1.2. Fresh Suspension Hepatocytes
- 5.1.3. 3D (Spheroid) Hepatocytes
- 5.1.4. Expanded Hepatocytes (Plateable)
- 5.1.5. Non-characterized Hepatocytes
- 5.2. Europe Primary Hepatocytes Market Outlook, by Species, Value (US$ Bn), 2020-2033
- 5.2.1. Human
- 5.2.2. Rat
- 5.2.3. Mouse
- 5.2.4. Dog
- 5.2.5. Monkey
- 5.2.6. Horse
- 5.2.7. Others
- 5.3. Europe Primary Hepatocytes Market Outlook, by Application/Assay, Value (US$ Bn), 2020-2033
- 5.3.1. Cell Viability Assay
- 5.3.2. Cytochrome Enzyme Activity
- 5.3.3. High Content Cytotoxicity
- 5.3.4. Transporter Inhibition Assay
- 5.3.5. In Vitro Intrinsic Clearance
- 5.3.6. Phospholipids Assay
- 5.3.7. Others
- 5.4. Europe Primary Hepatocytes Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 5.4.1. Biopharmaceutical companies
- 5.4.2. Academic and Research institutes
- 5.4.3. Contract Research Organizations
- 5.5. Europe Primary Hepatocytes Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 5.5.1. Germany Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 5.5.2. Germany Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 5.5.3. Germany Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 5.5.4. Germany Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 5.5.5. Italy Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 5.5.6. Italy Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 5.5.7. Italy Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 5.5.8. Italy Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 5.5.9. France Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 5.5.10. France Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 5.5.11. France Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 5.5.12. France Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 5.5.13. U.K. Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 5.5.14. U.K. Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 5.5.15. U.K. Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 5.5.16. U.K. Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 5.5.17. Spain Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 5.5.18. Spain Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 5.5.19. Spain Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 5.5.20. Spain Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 5.5.21. Russia Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 5.5.22. Russia Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 5.5.23. Russia Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 5.5.24. Russia Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 5.5.25. Rest of Europe Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 5.5.26. Rest of Europe Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 5.5.27. Rest of Europe Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 5.5.28. Rest of Europe Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 5.6. BPS Analysis/Market Attractiveness Analysis
6. Asia Pacific Primary Hepatocytes Market Outlook, 2020 - 2033
- 6.1. Asia Pacific Primary Hepatocytes Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 6.1.1. Cryopreserved Suspension Hepatocytes
- 6.1.2. Fresh Suspension Hepatocytes
- 6.1.3. 3D (Spheroid) Hepatocytes
- 6.1.4. Expanded Hepatocytes (Plateable)
- 6.1.5. Non-characterized Hepatocytes
- 6.2. Asia Pacific Primary Hepatocytes Market Outlook, by Species, Value (US$ Bn), 2020-2033
- 6.2.1. Human
- 6.2.2. Rat
- 6.2.3. Mouse
- 6.2.4. Dog
- 6.2.5. Monkey
- 6.2.6. Horse
- 6.2.7. Others
- 6.3. Asia Pacific Primary Hepatocytes Market Outlook, by Application/Assay, Value (US$ Bn), 2020-2033
- 6.3.1. Cell Viability Assay
- 6.3.2. Cytochrome Enzyme Activity
- 6.3.3. High Content Cytotoxicity
- 6.3.4. Transporter Inhibition Assay
- 6.3.5. In Vitro Intrinsic Clearance
- 6.3.6. Phospholipids Assay
- 6.3.7. Others
- 6.4. Asia Pacific Primary Hepatocytes Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 6.4.1. Biopharmaceutical companies
- 6.4.2. Academic and Research institutes
- 6.4.3. Contract Research Organizations
- 6.5. Asia Pacific Primary Hepatocytes Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 6.5.1. China Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 6.5.2. China Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 6.5.3. China Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 6.5.4. China Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 6.5.5. Japan Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 6.5.6. Japan Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 6.5.7. Japan Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 6.5.8. Japan Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 6.5.9. South Korea Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 6.5.10. South Korea Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 6.5.11. South Korea Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 6.5.12. South Korea Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 6.5.13. India Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 6.5.14. India Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 6.5.15. India Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 6.5.16. India Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 6.5.17. Southeast Asia Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 6.5.18. Southeast Asia Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 6.5.19. Southeast Asia Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 6.5.20. Southeast Asia Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 6.5.21. Rest of SAO Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 6.5.22. Rest of SAO Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 6.5.23. Rest of SAO Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 6.5.24. Rest of SAO Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 6.6. BPS Analysis/Market Attractiveness Analysis
7. Latin America Primary Hepatocytes Market Outlook, 2020 - 2033
- 7.1. Latin America Primary Hepatocytes Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 7.1.1. Cryopreserved Suspension Hepatocytes
- 7.1.2. Fresh Suspension Hepatocytes
- 7.1.3. 3D (Spheroid) Hepatocytes
- 7.1.4. Expanded Hepatocytes (Plateable)
- 7.1.5. Non-characterized Hepatocytes
- 7.2. Latin America Primary Hepatocytes Market Outlook, by Species, Value (US$ Bn), 2020-2033
- 7.2.1. Human
- 7.2.2. Rat
- 7.2.3. Mouse
- 7.2.4. Dog
- 7.2.5. Monkey
- 7.2.6. Horse
- 7.2.7. Others
- 7.3. Latin America Primary Hepatocytes Market Outlook, by Application/Assay, Value (US$ Bn), 2020-2033
- 7.3.1. Cell Viability Assay
- 7.3.2. Cytochrome Enzyme Activity
- 7.3.3. High Content Cytotoxicity
- 7.3.4. Transporter Inhibition Assay
- 7.3.5. In Vitro Intrinsic Clearance
- 7.3.6. Phospholipids Assay
- 7.3.7. Others
- 7.4. Latin America Primary Hepatocytes Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 7.4.1. Biopharmaceutical companies
- 7.4.2. Academic and Research institutes
- 7.4.3. Contract Research Organizations
- 7.5. Latin America Primary Hepatocytes Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 7.5.1. Brazil Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 7.5.2. Brazil Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 7.5.3. Brazil Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 7.5.4. Brazil Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 7.5.5. Mexico Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 7.5.6. Mexico Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 7.5.7. Mexico Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 7.5.8. Mexico Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 7.5.9. Argentina Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 7.5.10. Argentina Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 7.5.11. Argentina Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 7.5.12. Argentina Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 7.5.13. Rest of LATAM Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 7.5.14. Rest of LATAM Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 7.5.15. Rest of LATAM Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 7.5.16. Rest of LATAM Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 7.6. BPS Analysis/Market Attractiveness Analysis
8. Middle East & Africa Primary Hepatocytes Market Outlook, 2020 - 2033
- 8.1. Middle East & Africa Primary Hepatocytes Market Outlook, by Product Type, Value (US$ Bn), 2020-2033
- 8.1.1. Cryopreserved Suspension Hepatocytes
- 8.1.2. Fresh Suspension Hepatocytes
- 8.1.3. 3D (Spheroid) Hepatocytes
- 8.1.4. Expanded Hepatocytes (Plateable)
- 8.1.5. Non-characterized Hepatocytes
- 8.2. Middle East & Africa Primary Hepatocytes Market Outlook, by Species, Value (US$ Bn), 2020-2033
- 8.2.1. Human
- 8.2.2. Rat
- 8.2.3. Mouse
- 8.2.4. Dog
- 8.2.5. Monkey
- 8.2.6. Horse
- 8.2.7. Others
- 8.3. Middle East & Africa Primary Hepatocytes Market Outlook, by Application/Assay, Value (US$ Bn), 2020-2033
- 8.3.1. Cell Viability Assay
- 8.3.2. Cytochrome Enzyme Activity
- 8.3.3. High Content Cytotoxicity
- 8.3.4. Transporter Inhibition Assay
- 8.3.5. In Vitro Intrinsic Clearance
- 8.3.6. Phospholipids Assay
- 8.3.7. Others
- 8.4. Middle East & Africa Primary Hepatocytes Market Outlook, by End User, Value (US$ Bn), 2020-2033
- 8.4.1. Biopharmaceutical companies
- 8.4.2. Academic and Research institutes
- 8.4.3. Contract Research Organizations
- 8.5. Middle East & Africa Primary Hepatocytes Market Outlook, by Country, Value (US$ Bn), 2020-2033
- 8.5.1. GCC Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 8.5.2. GCC Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 8.5.3. GCC Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 8.5.4. GCC Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 8.5.5. South Africa Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 8.5.6. South Africa Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 8.5.7. South Africa Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 8.5.8. South Africa Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 8.5.9. Egypt Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 8.5.10. Egypt Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 8.5.11. Egypt Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 8.5.12. Egypt Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 8.5.13. Nigeria Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 8.5.14. Nigeria Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 8.5.15. Nigeria Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 8.5.16. Nigeria Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 8.5.17. Rest of Middle East Primary Hepatocytes Market Outlook, by Product Type, 2020-2033
- 8.5.18. Rest of Middle East Primary Hepatocytes Market Outlook, by Species, 2020-2033
- 8.5.19. Rest of Middle East Primary Hepatocytes Market Outlook, by Application/Assay, 2020-2033
- 8.5.20. Rest of Middle East Primary Hepatocytes Market Outlook, by End User, 2020-2033
- 8.6. BPS Analysis/Market Attractiveness Analysis
9. Competitive Landscape
- 9.1. Company Vs Segment Heatmap
- 9.2. Company Market Share Analysis, 2025
- 9.3. Competitive Dashboard
- 9.4. Company Profiles
- 9.4.1. Thermo Fisher Scientific Inc.
- 9.4.1.1. Company Overview
- 9.4.1.2. Product Portfolio
- 9.4.1.3. Financial Overview
- 9.4.1.4. Business Strategies and Developments
- 9.4.2. Corning Inc.
- 9.4.3. Lonza
- 9.4.4. Takara Bio Inc.
- 9.4.5. Cell Biologics, Inc.
- 9.4.6. Merck KGaA
- 9.4.7. American Type Culture Collection (ATCC)
- 9.4.8. Creative Bioarray
- 9.4.9. Axol Bioscience Ltd.
- 9.4.10. HiMedia Laboratories
- 9.4.1. Thermo Fisher Scientific Inc.
10. Appendix
- 10.1. Research Methodology
- 10.2. Report Assumptions
- 10.3. Acronyms and Abbreviations
